Chemfab Alkalis Ltd
Fundamental Score
Chemfab Alkalis Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of CHEMFAB across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (20.07%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Conservative Debt Levels (D/E: 0.29)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Balanced Promoter Holding (72.18%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
12 factors identified
Below-Average Return on Equity (2.33%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (3.32%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Premium Valuation Risk (P/E: 570.61x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-279.25%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-6.52%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Weak Earnings Growth (-20.51% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (-20.03% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
Negative Free Cash Flow (₹-17.76 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Limited Institutional Interest (FII+DII: 0.27%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Financial Statements
Comprehensive financial data for Chemfab Alkalis Ltd
About CHEMFAB
Business Overview
Chemfab Alkalis Limited, together with its subsidiary, Chemfab Alkalis Karaikal Limited, manufactures and sells inorganic chemicals in India and internationally. The company operates through Chemicals and Related Products/Services; and PVC-O Pipes segments. The company offers caustic soda lye and flakes, liquid chlorine, hydrogen gas, hydrochloric acid, and sodium hypochlorite/bleach liquor products; sodium chlorate; and alkali, acids, bases, solvents, alcohols, gases, ethers, aliphatics, aromatics, aldehydes ketones, amines, alkaloids, potassium chlorate, perchlorate, and other chemicals, as well as its by-products and derivatives. It also provides industrial grade and edible salt products; and PVCO pipes. The company was formerly known as Teamec Chlorates Limited and changed its name to Chemfab Alkalis Limited in July 2017. Chemfab Alkalis Limited was founded in 1985 and is based in Chennai, India.
Company Details
Key Leadership
Corporate Events
CHEMFAB Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Chemfab Alkalis Ltd (CHEMFAB)?
As of 09 Feb 2026, 12:24 pm IST, Chemfab Alkalis Ltd (CHEMFAB) is currently trading at ₹406.75. The stock has a market capitalization of ₹730.38 (Cr).
Is CHEMFAB share price Overvalued or Undervalued?
CHEMFAB is currently trading at a P/E ratio of 570.61x, compared to the industry average of 20.98x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Chemfab Alkalis Ltd share price?
Key factors influencing CHEMFAB's price include its quarterly earnings growth (Sales Growth: -6.52%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Chemfab Alkalis Ltd a good stock for long-term investment?
Chemfab Alkalis Ltd shows a 5-year Profit Growth of -20.03% and an ROE of 2.33%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.29 before investing.
How does Chemfab Alkalis Ltd compare with its industry peers?
Chemfab Alkalis Ltd competes with major peers in the Commodity Chemicals. Investors should compare CHEMFAB's P/E of 570.61x and ROE of 2.33% against the industry averages to determine its competitive standing.
What is the P/E ratio of CHEMFAB and what does it mean?
CHEMFAB has a P/E ratio of 570.61x compared to the industry average of 20.98x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹571 for every ₹1 of annual earnings.
How is CHEMFAB performing according to Bull Run's analysis?
CHEMFAB has a Bull Run fundamental score of 18.2/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does CHEMFAB belong to?
CHEMFAB operates in the Commodity Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Chemfab Alkalis Ltd.
What is Return on Equity (ROE) and why is it important for CHEMFAB?
CHEMFAB has an ROE of 2.33%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Chemfab Alkalis Ltd generates profits from shareholders' equity.
How is CHEMFAB's debt-to-equity ratio and what does it indicate?
CHEMFAB has a debt-to-equity ratio of 0.29, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is CHEMFAB's dividend yield and is it a good dividend stock?
CHEMFAB offers a dividend yield of 0.25%, which means you receive ₹0.25 annual dividend for every ₹100 invested.
How has CHEMFAB grown over the past 5 years?
CHEMFAB has achieved 5-year growth rates of: Sales Growth 10.33%, Profit Growth -20.03%, and EPS Growth -20.51%.
What is the promoter holding in CHEMFAB and why does it matter?
Promoters hold 72.18% of CHEMFAB shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is CHEMFAB's market capitalization category?
CHEMFAB has a market capitalization of ₹730 crores, placing it in the Small-cap category.
How volatile is CHEMFAB stock?
CHEMFAB has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for CHEMFAB?
CHEMFAB has a 52-week high of ₹N/A and low of ₹N/A.
What is CHEMFAB's operating profit margin trend?
CHEMFAB has a 5-year average Operating Profit Margin (OPM) of 20.07%, indicating the company's operational efficiency.
How is CHEMFAB's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -6.52% and YoY Profit Growth of -279.25%.
What is the institutional holding pattern in CHEMFAB?
CHEMFAB has FII holding of 0.00% and DII holding of 0.27%. Significant institutional holding often suggests professional confidence in the stock.